首页> 外国专利> PROCESS FOR MAKING DERIVATIVES OF PYRIMIDINE-THIO-ALKYL-PYRIDINE

PROCESS FOR MAKING DERIVATIVES OF PYRIMIDINE-THIO-ALKYL-PYRIDINE

机译:制备嘧啶-硫代烷基-吡啶的衍生物的方法

摘要

1. Claims for the contracting states : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE Pyrimidine-thioalkylpyridine derivatives corresponding to the general formula see diagramm : EP0124630,P12,F5 wherein R1 to R4 denote, independently of one another, hydrogen, C1 -C4 alkyl, halogen, amino or hydroxyl groups, R5 denotes a free electron pair or a C1 to C4 alkyl group, X denotes a halogen atom when R5 denotes a C1 -C4 alkyl group, m has the value 0 or 1, and the pyrimidine-thioalkyl group is attached in the 2-, 3- or 4-position of the pyridine ring, and their therapeutically acceptable acid addition salts. 1. Claims for the contracting state : AT Process for the preparation of pyrimidine- thioalkylpyridine derivatives corresponding to the general formula I see diagramm : EP0124630,P13,F1 wherein R1 to R4 denote, independently of one another, hydrogen, C1 -C4 alkyl, halogen, amino or hydroxyl groups, R5 denotes a free electron pair or a C1 -C4 -alkyl group, X stands for a halogen atom when R5 stands for a C1 -C4 alkyl group, m has the value 0 or 1, and the pyrimidine-thioalkyl group is attached in the 2-, 3- or 4-position of the pyridine ring, and their therapeutically acceptable acid addition salts, characterised in that a) for the preparation of compounds corresponding to the general formula I in which m has the value 0, a compound corresponding to formula II see diagramm : EP0124630,P13,F4 wherein R1 and R2 have the meaning indicated above and Me stands for an alkali metal atom is reacted with a picolyl chloride hydrohalide corresponding to the general formula III see diagramm : EP0124630,P13,F6 wherein Hal denotes a halogen atom and in which the chloromethyl group is in the 2, -3- or 4-position of the pyridine group and R3 and R4 have the meaning indicated above, in the aqueous alcoholic alkali metal hydroxide solution, the alkali metal hydroxide being present in excess of the stoichiometric quantity, or in that b) for the preparation of compounds in which m has the value 1, a compound corresponding to the general formula IV see diagramm : EP0124630,P13,F8 wherein R1 to R4 have the meanings indicated above, has added thereto an aquimolar proportion of an oxidising agent in an inert solvent and the resulting sulphinyl compound corresponding to the general formula V see diagramm : EP0124630,P14,F2 is isolated, or c) for the preparation of compounds in which m has the value 0, a pyrimidine-thioalkylpyridine derivative corresponding to the general formula IV see diagramm : EP0124630,P14,F3 wherein R1 to R4 have the meanings indicated above is reacted in a solvent with an equimolar quantity of an alkyl halide to form a compound corresponding to the general formula VI see diagramm : EP0124630,P14,F4 and d) optionally the compound obtained in a) to c) is converted into a physiologically acceptable salt.
机译:1.合同项下的权利要求:BE,CH,DE,FR,GB,IT,LI,LU,NL,SE对应于通式的嘧啶-硫代烷基吡啶衍生物,见图:EP0124630,P12,F5其中R1至R4表示,氢,C 1 -C 4烷基,卤素,氨基或羟基彼此独立地,R 5表示自由电子对或C 1 -C 4烷基,当R 5表示C 1 -C 4烷基时,X表示卤素原子,m具有值为0或1,且嘧啶-硫代烷基与吡啶环及其治疗上可接受的酸加成盐连接在吡啶环的2-,3-或4-位。 1.收缩状态的要求:AT制备对应于通式I的嘧啶-硫代烷基吡啶衍生物的方法,参见图:EP0124630,P13,F1,其中R1-R4彼此独立地表示氢,C1-C4烷基,卤素,氨基或羟基,R5表示自由电子对或C1-C4-烷基,X表示卤原子,R5表示C1-C4烷基,m值为0或1,嘧啶-硫代烷基连接在吡啶环的2-,3-或4-位以及它们的治疗上可接受的酸加成盐,其特征在于,a)用于制备对应于通式I的化合物,其中m具有值为0时,对应于式II的化合物参见图:EP0124630,P13,F4其中R1和R2具有上述含义,Me代表碱金属原子与对应于通式III的甲基吡啶氯氢卤化物反应,参见图: EP 0124630,P13,F6其中Hal表示卤原子,其中氯甲基位于吡啶基的2,-3-或4-位,且R3和R4具有上述含义,在含水的碱金属氢氧化物中溶液,碱金属氢氧化物的存在量超过化学计量的量,或b)用于制备其中m的值为1的化合物,对应于通式IV的化合物,参见图:EP0124630,P13,F8 R1至R4具有上述含义,在惰性溶剂中向其中加入了等摩尔比例的氧化剂,并且所得到的对应于通式V的亚磺酰基化合物参见图:EP0124630,P14,F2被分离,或c)制备其中m值为0的化合物时,对应于通式IV的嘧啶-硫代烷基吡啶衍生物见图:EP0124630,P14,F3其中R1至R4具有上述含义,在具有等摩尔量的卤代烷的溶剂形成对应于通式VI的化合物,参见图:EP0124630,P14,F4和d)任选地将在a)至c)中获得的化合物转化成生理上可接受的盐。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号